Novartis AG - SWOT, Strategy and Corporate Finance Report
Novartis AG - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360˚ view of the company.
Detailed information on Novartis AG required for business and competitor intelligence needs
A study of the major internal and external factors affecting Novartis AG in the form of a SWOT analysis
An in-depth view of the business model of Novartis AG including a breakdown and examination of key business segments
Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Novartis AG
Intelligence on Novartis AGnv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Novartis AG, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Novartis (or ‘the company’) is one of the Big Pharma companies having strong presence in diverse biopharmaceutical segments. It is engaged in the research, development, manufacture and marketing of branded drugs, generic pharmaceutical products, preventive vaccines, diagnostic tools and consumer health products. The company operates in more than 140 countries. It is headquartered in Basel, Switzerland, and employed 128,000 people as of December 31, 2012. The company recorded revenues of $56,673 million during the financial year ended December 2012 (FY2012), a decrease of 3.2% over FY2011. The operating profit of the company was $11,511 million in FY2012, an increase of 4.7% over FY2011. The net profit was $9,505 million in FY2012, an increase of 4.3% over FY2011.
Reasons to Purchase:
Gain understanding of Novartis AG and the factors that influence its strategies
Track strategic initiatives of the company and latest corporate news and actions
Assess Novartis AG as a prospective partner, vendor or supplier
Support sales activities by understanding your customers' businesses better
Stay up to date on Novartis AG’s business structure, strategy and prospects